FGP timeline
Every FGP batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| FGP-2605-R1831 | Tirzepatide | 25 May 2026 | 2026-Q2 | 15 | 97.70 | 1.89 | 98.48 | +0.78 | |
| FGP-2604-K1470 | MK-677 (Ibutamoren mesylate) | 01 Apr 2026 | 2026-Q2 | 2 | 99.93 | 0.00 | 99.90 | -0.03 | |
| FGP-2603-L9714 | Tirzepatide | 16 Mar 2026 | 2026-Q3 | 4 | 99.00 | 1.30 | 99.19 | +0.19 | |
| FGP-2602-M9870 | Cagrilintide | 28 Feb 2026 | 2026-Q2 | 4 | 98.73 | 1.44 | 98.94 | +0.21 | |
| FGP-2602-Y1702 | PT-141 (Bremelanotide) | 17 Feb 2026 | 2026-Q2 | 6 | 99.93 | 0.51 | 99.90 | -0.03 | |
| FGP-2602-M1508 | Semaglutide | 13 Feb 2026 | 2026-Q3 | 9 | 99.23 | 1.14 | 99.63 | +0.40 | |
| FGP-2601-V1242 | CJC-1295 (no DAC) | 16 Jan 2026 | 2026-Q2 | 4 | 99.93 | 0.00 | 101.00 | +1.07 | |
| FGP-2601-T1617 | TB-500 | 16 Jan 2026 | 2026-Q1 | 9 | 99.93 | 0.59 | 99.90 | -0.03 | |
| FGP-2601-R1916 | SS-31 (Elamipretide) | 14 Jan 2026 | 2026-Q2 | 4 | 99.83 | 0.51 | 99.90 | +0.07 | |
| FGP-2601-E2289 | BPC-157 | 01 Jan 2026 | 2026-Q2 | 5 | 99.28 | 0.96 | 99.48 | +0.20 | |
| FGP-2512-A2448 | BPC-157 | 24 Dec 2025 | 2026-Q1 | 11 | 99.93 | 0.74 | 99.90 | -0.03 | |
| FGP-2512-V2097 | Retatrutide | 14 Dec 2025 | 2026-Q1 | 3 | 98.70 | 0.43 | 98.93 | +0.23 | |
| FGP-2512-Y9750 | TB-500 | 07 Dec 2025 | 2026-Q2 | 4 | 99.82 | 0.56 | 99.90 | +0.08 | |
| FGP-2511-D1094 | Selank | 20 Nov 2025 | 2026-Q1 | 9 | 99.93 | 0.28 | 99.90 | -0.03 | |
| FGP-2511-H2692 | Thymosin α1 | 10 Nov 2025 | 2026-Q1 | 3 | 98.89 | 1.14 | 99.72 | +0.83 | |
| FGP-2509-H2645 | PT-141 (Bremelanotide) | 22 Sep 2025 | 2025-Q4 | 7 | 99.93 | 0.04 | 99.90 | -0.03 | |
| FGP-2508-R1956 | N-Acetyl Semax Amide | 23 Aug 2025 | 2025-Q3 | 2 | 99.49 | 0.48 | 99.87 | +0.38 | |
| FGP-2508-S1106 | TB-500 | 19 Aug 2025 | 2025-Q4 | 6 | 99.40 | 0.78 | 99.90 | +0.50 | |
| FGP-2508-C2848 | CJC-1295 (no DAC) | 19 Aug 2025 | 2025-Q3 | 1 | 99.44 | n<2 | 99.90 | +0.46 | |
| FGP-2508-L2918 | PT-141 (Bremelanotide) | 01 Aug 2025 | 2025-Q3 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| FGP-2507-L2691 | LL-37 | 30 Jul 2025 | 2025-Q3 | 2 | 99.54 | 0.78 | 99.90 | +0.36 | |
| FGP-2506-L1816 | KPV | 16 Jun 2025 | 2025-Q3 | 6 | 99.70 | 0.60 | 99.90 | +0.20 | |
| FGP-2506-J9812 | Semaglutide | 02 Jun 2025 | 2025-Q4 | 13 | 99.69 | 0.51 | 99.90 | +0.21 | |
| FGP-2505-K1249 | PT-141 (Bremelanotide) | 25 May 2025 | 2025-Q4 | 9 | 99.24 | 1.28 | 99.45 | +0.21 | |
| FGP-2504-V9993 | Exenatide | 30 Apr 2025 | 2025-Q2 | 8 | 98.92 | 1.48 | 98.88 | -0.04 | |
| FGP-2503-P1477 | CJC-1295 (no DAC) | 01 Mar 2025 | 2025-Q1 | 5 | 99.29 | 0.58 | 99.74 | +0.45 | |
| FGP-2502-F9841 | MK-677 (Ibutamoren mesylate) | 03 Feb 2025 | 2025-Q2 | 6 | 99.48 | 0.92 | 99.90 | +0.42 | |
| FGP-2502-E1024 | NAD+ | 02 Feb 2025 | 2025-Q3 | 2 | 99.50 | 0.86 | 99.74 | +0.24 | |
| FGP-2501-A1918 | KPV | 30 Jan 2025 | 2025-Q2 | 8 | 99.93 | 0.10 | 99.90 | -0.03 | |
| FGP-2501-G1375 | L-Carnosine | 22 Jan 2025 | 2025-Q1 | 6 | 99.88 | 0.36 | 99.90 | +0.02 | |
| FGP-2501-F1566 | SS-31 (Elamipretide) | 07 Jan 2025 | 2025-Q2 | 8 | 99.93 | 0.39 | 99.90 | -0.03 | |
| FGP-2501-S9984 | Retatrutide | 01 Jan 2025 | 2025-Q1 | 5 | 98.68 | 1.44 | 99.07 | +0.39 | |
| FGP-2412-N1589 | Tirzepatide | 21 Dec 2024 | 2025-Q2 | 4 | 98.60 | 0.27 | 99.46 | +0.86 | |
| FGP-2411-A1460 | MOTS-c | 24 Nov 2024 | 2024-Q4 | 8 | 99.74 | 0.59 | 99.90 | +0.16 | |
| FGP-2411-J1249 | GHRP-6 | 15 Nov 2024 | 2025-Q2 | 9 | 99.93 | 0.62 | 99.90 | -0.03 | |
| FGP-2410-J9675 | CJC-1295 (no DAC) | 16 Oct 2024 | 2024-Q4 | 2 | 99.80 | 0.26 | 99.90 | +0.10 | |
| FGP-2409-Y1557 | BPC-157 | 23 Sep 2024 | 2025-Q1 | 3 | 99.48 | 0.38 | 99.90 | +0.42 | |
| FGP-2409-W2037 | PT-141 (Bremelanotide) | 22 Sep 2024 | 2025-Q1 | 5 | 99.93 | 0.44 | 99.90 | -0.03 | |
| FGP-2409-T2292 | Ipamorelin | 06 Sep 2024 | 2024-Q4 | 11 | 99.55 | 0.96 | 99.89 | +0.34 | |
| FGP-2408-H1549 | Tirzepatide | 28 Aug 2024 | 2024-Q4 | 6 | 99.69 | 0.85 | 99.72 | +0.03 | |
| FGP-2408-K1521 | L-Glutathione (reduced) | 21 Aug 2024 | 2024-Q3 | 9 | 99.88 | 0.36 | 99.90 | +0.02 | |
| FGP-2408-S1457 | Dihexa | 19 Aug 2024 | 2025-Q1 | 1 | 99.49 | n<2 | 99.90 | +0.41 | |
| FGP-2407-A2105 | BPC-157 | 07 Jul 2024 | 2024-Q3 | 3 | 99.72 | 0.19 | 99.90 | +0.18 | |
| FGP-2406-N1650 | Leuprolide | 20 Jun 2024 | 2024-Q3 | 1 | 98.96 | n<2 | 99.90 | +0.94 | |
| FGP-2406-W1827 | Oxytocin | 03 Jun 2024 | 2024-Q4 | 2 | 99.54 | 0.02 | 99.90 | +0.36 | |
| FGP-2406-D1606 | Sermorelin | 02 Jun 2024 | 2024-Q3 | 10 | 99.33 | 0.89 | 99.90 | +0.57 | |
| FGP-2405-E2221 | L-Glutathione (reduced) | 21 May 2024 | 2024-Q3 | 9 | 99.74 | 0.68 | 99.90 | +0.16 | |
| FGP-2402-D2141 | Ipamorelin | 09 Feb 2024 | 2024-Q3 | 7 | 99.91 | 0.81 | 99.90 | -0.01 | |
| FGP-2402-X1108 | TB-500 | 01 Feb 2024 | 2024-Q2 | 7 | 99.74 | 0.58 | 99.90 | +0.16 | |
| FGP-2312-X1645 | GHRP-6 | 01 Dec 2023 | 2024-Q2 | 11 | 99.44 | 0.98 | 99.90 | +0.46 | |
| FGP-2309-U2616 | Gonadorelin | 01 Sep 2023 | 2024-Q1 | 1 | 99.04 | n<2 | 99.90 | +0.86 |